3M plans to spin out $8.5B health­care di­vi­sion in­to its own com­pa­ny

While its name brings to mind sticky notes and pack­ag­ing tape, 3M al­so man­u­fac­tures a range of con­sumer and com­mer­cial prod­ucts from ban­dages to bio­med­ical pu­rifi­ca­tion sys­tems. Now the man­u­fac­tur­er plans to spin out its health­care prod­ucts di­vi­sion in­to a sep­a­rate pub­licly trad­ed com­pa­ny.

The Min­neso­ta-based man­u­fac­tur­er an­nounced last week that it plans to con­tin­ue in the ma­te­r­i­al sci­ence sec­tor, fo­cused on mak­ing prod­ucts re­lat­ed to wound care, health­care IT, oral care and bio­phar­ma fil­tra­tion. In the bio­phar­ma in­dus­try, 3M’s prod­ucts are used in the man­u­fac­tur­ing of vac­cines and re­com­bi­nant pro­teins.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER